{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04344",
      "entity_text" : "IFX",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0923" ],
      "Organ" : [ "uberon:UBERON:2001054" ],
      "Species" : [ "taxonomy:76720" ]
    }
  },
  "verbose_text" : "When we compared ADA positive sera which showed seroconversion for the first time with ADA negative sera which were taken at the time points (6.1 +/- 1.3 months) when ADA negative patients presented impaired clinical response, serum trough levels of IFX were significantly decreased in the ADA positive sera compared with the ADA negative sera (0.09 +/- 0.03 vs. 2.48 +/- 0.33 mug/mL; p < 0.0001).",
  "reading_complete" : "2020-08-08T15:34:33Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T15:30:58Z",
  "trigger" : "levels",
  "evidence" : [ "levels of IFX" ],
  "pmc_id" : "5028026",
  "score" : 0
}